Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonia Moretti

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
International Journal of Molecular Sciences|March 29, 2023
Turning a Tumor Microenvironment Pitfall into Opportunity: Discovery of Benzamidoxime as PD-L1 Ligand with pH-Dependent PotencyElisa Bianconi, Alessandra Riccio, Luana Ruta, et al.
Clinical Endocrinology|January 13, 2006
Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns))Claudio Carta, Sonia Moretti, Lucia Passeri, et al.
Expert Opinion on Emerging Drugs|March 16, 2007
Problems and emerging approaches in HIV/AIDS vaccine developmentFausto Titti, Aurelio Cafaro, Flavia Ferrantelli, et al.
Pathogens (Basel, Switzerland)|September 28, 2023
Monitoring Monkeypox: Safeguarding Global Health through Rapid Response and Global SurveillanceMarta Giovanetti, Eleonora Cella, Sonia Moretti, et al.
Cell Death & Disease|February 23, 2018
Long glucocorticoid-induced leucine zipper regulates human thyroid cancer cell proliferationEmira Ayroldi, Maria Grazia Petrillo, Maria Cristina Marchetti, et al.
Oncology Reports|August 19, 2011
Sunitinib inhibits tumor vascularity and growth but does not affect Akt and ERK phosphorylation in xenograft tumorsPasquale Voce, Maria D'Agostino, Sonia Moretti, et al.
European Journal of Endocrinology|May 2, 2003
Ret/PTC activation does not influence clinical and pathological features of adult papillary thyroid carcinomasEfisio Puxeddu, Sonia Moretti, Angela Giannico, et al.
The Journal of Biological Chemistry|October 14, 2003
Microsomal prostaglandin E2 synthase-1 is induced by conditional expression of RET/PTC in thyroid PCCL3 cells through the activation of the MEK-ERK pathwayEfisio Puxeddu, Norisato Mitsutake, Jeffrey A Knauf, et al.
Expert Review of Vaccines|December 16, 2017
"cART intensification by the HIV-1 Tat B clade vaccine: progress to phase III efficacy studies"Aurelio Cafaro, Cecilia Sgadari, Orietta Picconi, et al.
The Journal of Clinical Endocrinology and Metabolism|March 19, 2019
Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: An ATC-Like and a PDTC-LikeRiccardo Giannini, Sonia Moretti, Clara Ugolini, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Sciences|March 29, 2023
Turning a Tumor Microenvironment Pitfall into Opportunity: Discovery of Benzamidoxime as PD-L1 Ligand with pH-Dependent PotencyElisa Bianconi, Alessandra Riccio, Luana Ruta, et al.
Clinical Endocrinology|January 13, 2006
Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns))Claudio Carta, Sonia Moretti, Lucia Passeri, et al.
Expert Opinion on Emerging Drugs|March 16, 2007
Problems and emerging approaches in HIV/AIDS vaccine developmentFausto Titti, Aurelio Cafaro, Flavia Ferrantelli, et al.
Pathogens (Basel, Switzerland)|September 28, 2023
Monitoring Monkeypox: Safeguarding Global Health through Rapid Response and Global SurveillanceMarta Giovanetti, Eleonora Cella, Sonia Moretti, et al.
Cell Death & Disease|February 23, 2018
Long glucocorticoid-induced leucine zipper regulates human thyroid cancer cell proliferationEmira Ayroldi, Maria Grazia Petrillo, Maria Cristina Marchetti, et al.
Oncology Reports|August 19, 2011
Sunitinib inhibits tumor vascularity and growth but does not affect Akt and ERK phosphorylation in xenograft tumorsPasquale Voce, Maria D'Agostino, Sonia Moretti, et al.
European Journal of Endocrinology|May 2, 2003
Ret/PTC activation does not influence clinical and pathological features of adult papillary thyroid carcinomasEfisio Puxeddu, Sonia Moretti, Angela Giannico, et al.
The Journal of Biological Chemistry|October 14, 2003
Microsomal prostaglandin E2 synthase-1 is induced by conditional expression of RET/PTC in thyroid PCCL3 cells through the activation of the MEK-ERK pathwayEfisio Puxeddu, Norisato Mitsutake, Jeffrey A Knauf, et al.
Expert Review of Vaccines|December 16, 2017
"cART intensification by the HIV-1 Tat B clade vaccine: progress to phase III efficacy studies"Aurelio Cafaro, Cecilia Sgadari, Orietta Picconi, et al.
The Journal of Clinical Endocrinology and Metabolism|March 19, 2019
Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: An ATC-Like and a PDTC-LikeRiccardo Giannini, Sonia Moretti, Clara Ugolini, et al.
Pageof 7